MiR-222 overexpression confers cell migratory advantages in hepatocellular carcinoma through enhancing AKT signaling

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Queenie W-L WongNathalie Wong

Abstract

This study aims to profile the expressions of 156 microRNAs (miRNA) in hepatocellular carcinoma (HCC) and to characterize the functions of miR-222, the most significantly upregulated candidate identified. miRNA expression profile in HCC tumors, matching adjacent cirrhotic livers, and cell lines was conducted using quantitative PCR. Common miR-222 upregulations were further validated in a larger cohort of tumors. The functional effects of miR-222 inhibition on HCC cell lines were examined. The downstream modulated pathways and target of miR-222 were investigated by coupling gene expression profiling and pathway analysis, and by in silico prediction, respectively. Luciferase reporter assay was done to confirm target interaction. We identified a 40-miRNA signature that could discriminate tumors from adjacent cirrhotic liver tissue, and further corroborated common miR-222 overexpression in tumors relative to its premalignant counterpart (55.3%; P < 0.0001). Increased miR-222 expression correlated significantly with advanced stage HCC and with the shorter disease-free survival of patients (P < or = 0.01). Inhibition of miR-222 in Hep3B and HKCI-9 significantly retarded cell motility (P < 0.05). Further investigations suggested that ...Continue Reading

Citations

Sep 1, 2012·Cellular and Molecular Life Sciences : CMLS·Min Xu, Yin-Yuan Mo
Jan 8, 2013·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Wenjia LouCheng Qian
Oct 15, 2010·Expert Reviews in Molecular Medicine·Bo Song, Jingfang Ju
Feb 9, 2011·Proceedings of the National Academy of Sciences of the United States of America·Mattia BoeriGabriella Sozzi
Mar 31, 2012·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Yu WangCaroline G L Lee
Feb 22, 2011·Journal of Gastroenterology and Hepatology·Priscilla T-Y Law, Nathalie Wong
Apr 13, 2011·PloS One·Sujaya SrinivasanKumaravel Somasundaram
Aug 29, 2013·World Journal of Gastroenterology : WJG·Catherine M GreeneMatthew W Lawless
Sep 12, 2013·World Journal of Gastroenterology : WJG·Sharad KhareJamal A Ibdah
Mar 16, 2011·Pathology Research International·Nicole C Panarelli, Rhonda K Yantiss
May 10, 2011·International Journal of Biological Sciences·Naoki Oishi, Xin Wei Wang
Feb 6, 2014·Life Sciences·Cristian TuratoPatrizia Pontisso
Feb 23, 2013·TheScientificWorldJournal·Jie SunHongchuan Jin
Jun 19, 2014·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Jun LvQian Wang
Feb 27, 2014·Virchows Archiv : an International Journal of Pathology·Mónika GyugosAndrás Kiss
Aug 20, 2014·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Ting-Yi SunLiang Liu
May 16, 2014·International Journal of Molecular Sciences·Ying-Chun HeDeliang Cao
Dec 25, 2015·Nature Reviews. Rheumatology·Rita VicenteChristian Jorgensen
Jan 23, 2016·Journal of Cellular and Molecular Medicine·Li-Ping ZengKun Xia
Jul 22, 2014·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Asahiro Morishita, Tsutomu Masaki
Nov 16, 2011·Seminars in Oncology·Chiara BraconiTushar Patel
Aug 9, 2011·Biochimica Et Biophysica Acta·Ajit Kumar
Apr 26, 2011·Mutation Research·Bahaeldin K ElaminMassimo Negrini
Oct 31, 2012·Science China. Life Sciences·Xue ZhaoHaitao Zhao
Nov 26, 2015·Critical Reviews in Oncology/hematology·Fabrizio BronteAntonio Russo
Sep 11, 2014·Pharmacology & Therapeutics·Ioannis AnestopoulosMihalis I Panayiotidis
Feb 11, 2015·Molecular and Cellular Endocrinology·Carolyn M Klinge

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.